The Human Upgrade: Biohacking for Longevity & Performance

The Tiny Implant Replacing Life-Changing Drugs | Biohacking Tools : 1365

47 snips
Nov 18, 2025
In this discussion, Dr. Kevin J. Tracey, a pioneering figure in vagus nerve research and CEO of the Feinstein Institutes, shares groundbreaking insights on bioelectronic medicine. He reveals how targeted nerve stimulation might replace traditional drugs for conditions like rheumatoid arthritis, emphasizing the importance of specific pathways for inflammation control. Dr. Tracey also delves into the potential for vagal boosting to enhance longevity and metabolism while addressing safety concerns of neural implants. The future of health could be electric!
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Bioelectronic Medicine Reframes Drug Therapy

  • Bioelectronic medicine targets molecular mechanisms by using neurotransmitters and nerve pathways instead of traditional drugs.
  • Devices drive pulses into nerves to evoke biological responses with precision when the molecular target is known.
ANECDOTE

From Napkin Sketch To Clinical Trial

  • Kevin Tracey described designing a vagus nerve stimulator sketched on a napkin to treat rheumatoid arthritis decades ago.
  • That idea led to SetPoint and a positive randomized trial with an implant sized like a multivitamin.
INSIGHT

Specificity Requires Implants Or Focused Ultrasound

  • Two specific ways to target neural pathways are implantable electrodes and focused ultrasound.
  • Transcutaneous skin stimulation usually lacks the specificity to target deep vagal fibers reliably.
Get the Snipd Podcast app to discover more snips from this episode
Get the app